AKRX, LXRX Get FDA Nod, KITE Flies Higher, SRPT Plunges On Dull Outlook

Akorn Inc. (AKRX) has received FDA approval for Mycophenolate Mofetil for Injection, USP, 500 mg/vial, a generic version of immunosuppressant CellCept.

from RTT - Biotech http://ift.tt/2laPJnZ
via IFTTT